Granite Bay Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Granite Bay Wealth Management's MRNA Position: Q1 2024 in Review
Granite Bay Wealth Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 4,413 shares — an estimated $394K sold.
Granite Bay Wealth Management first reported a position in MRNA in Q3 2023 and held it in 2 quarters. The position peaked at $1.76M in Q3 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.
- Granite Bay Wealth Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
- Granite Bay Wealth Management sold 4,413 Moderna shares in Q1 2024, an estimated $394K.
- Granite Bay Wealth Management first reported a position in Moderna in Q3 2023 and held it in 2 quarters.
- Granite Bay Wealth Management's Moderna position peaked at $1.76M in Q3 2023.
- 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.
Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.